Vol 13, No 3 (June 27, 2025): Annals of Translational Medicine

Dazukibart for dermatomyositis: expanding the therapeutic arsenal

Breaking new ground in ductal carcinoma in situ management: the promise of intratumoral messenger ribonucleic acid-2752 and pembrolizumab

The 6-methyladenine erasers ALKBH5 and FTO influence chemotherapy efficiency in bladder cancer cell lines

An investigational time-course study using an in vivo ovine laminectomy model for the neurohistopathological evaluation of hemostatic agents

Development of stromal corneal grafts using a novel decellularization method with sodium cocoyl glutamate on GGTA1/CMAH/β4GalNT2 knock-out porcine corneas

Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy

Obesity-induced left atrial dysfunction across age groups and cardiovascular conditions: a comprehensive review of diagnostic advances and clinical implications

Climate change and environmental sustainability in emergency medicine: a narrative review

Raltitrexed as a substitute for 5-fluorouracil in combination with pembrolizumab and platinum in a patient with metastatic esophageal squamous cell carcinoma and coronary artery disease: a case report

Erratum to LXA4 protects against blue-light induced retinal degeneration in human A2E-laden RPE cells and Balb-c mice

Erratum to protective effect of ischemic postconditioning on ischemia reperfusion injury in steatotic rat livers

Erratum to Phosphorylated nuclear factor erythroid 2-related factor 2 promotes the secretion of C-C motif chemokine ligand 2 and the recruitment of M2 macrophages

Retraction: MicroRNA-377-3p targeting MMP-16 inhibits ovarian cancer cell growth, invasion, and interstitial transition